Biotech Series B Investors & VC Firms
724 firms in this list, with a median first check of $500K. 165 of them lead rounds. Generated from verified public data and updated continuously.
Monograph Capital Partners
LondonSeed–Series B
21 people
Miyako Capital
KyotoSeed–Late Stage
14 people
Dimension Capital
San FranciscoSeed–Growth$1M – $10M
16 people
SpringTide Ventures
BostonSeed–Series B$500K – $5M
15 people
Qiming Venture Partners USA
CambridgeSeed–Series B
19 people
Unorthodox Ventures
AustinSeed–Growth$1M – $5M
16 people
growX Ventures
BangalorePre-Seed–Growth
13 people
Starlight Ventures
MiamiPre-Seed–Series B$100K – $3M
7 people
MDI Ventures
JakartaPre-Seed–Growth
12 people
Xiang He Capital
BeijingSeed–Series B
3 people
DCVC Bio
Palo AltoSeed–Growth
14 people
SQN Venture Partners, LLC
CharlestonSeed–Growth
11 people
Sonder Capital
San CarlosPre-Seed–Series C
17 people
Neva Sgr.
TurinSeries A–Growth
8 people
Starquest Capital
ParisSeed–Growth$550K – $22M
13 people
Venture Ontario
TorontoSeed–Growth
3 people
Medical Excellence Capital
New YorkSeed–Series B
19 people
BRM Capital
Tel AvivSeed–Growth
14 people
Wormhole Capital
Pre-Seed–Growth
2 people
Thorney Investment Group
MelbourneSeed–Late Stage
25 people
DeepWork Capital
OrlandoSeed–Series B
11 people
Black Opal Ventures
New YorkSeed–Late Stage
18 people
Auriga Partners
ParisSeed–Growth$540K – $5.4M
16 people
Quan Capital
ShanghaiSeed–Growth
17 people
Related lists
Series B Investors & VC Firms (2951)Biotech Investors & VC Firms (2483)Biotech Seed Investors & VC Firms (2027)Series B Investors & VC Firms in North America (1738)Biotech Series A Investors & VC Firms (1627)Biotech Investors & VC Firms in North America (1601)Series B Investors & VC Firms in United States (1573)Biotech Investors & VC Firms in United States (1450)SaaS Series B Investors & VC Firms (1075)Series B Investors & VC Firms in Europe (1073)
Data sourced from public filings and firms' own websites — see our methodology.





























































































